Author: Davies N.M.
Publisher: Adis International
ISSN: 0312-5963
Source: Clinical Pharmacokinetics, Vol.35, Iss.6, 1998-12, pp. : 425-436
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A critical assessment of oxaprozin clinical profile in rheumatic diseases
By Kean Walter F. Kean Robert Buchanan W. Watson
Inflammopharmacology, Vol. 10, Iss. 3, 2002-08 ,pp. :
Bicalutamide: Clinical Pharmacokinetics and Metabolism
Clinical Pharmacokinetics, Vol. 43, Iss. 13, 2004-01 ,pp. :
Clinical Pharmacokinetics of Metformin
Clinical Pharmacokinetics, Vol. 50, Iss. 2, 2011-02 ,pp. :
Clinical Pharmacokinetics of Mibefradil
By Welker H.A. Wiltshire H. Bullingham R.
Clinical Pharmacokinetics, Vol. 35, Iss. 6, 1998-12 ,pp. :